Article Text

Download PDFPDF

Journal club summaries
What's hot that the other lot got
Free
  1. Elizabeth Batalla-Duran
  1. Correspondence to Dr Elizabeth Batalla-Duran, Royal Devon and Exeter Hospital, Exeter EX2 5DW, UK; ebatalla-duran{at}nhs.net

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Platelets in pneumonia

It is not uncommon to see thrombocytosis or thrombocytopenia in patients with pneumonia. This study (Platelets doi: 10.1080/09537104.2016.1219032) investigated whether platelet count on admission, at discharge, or change in platelets during admission had any prognostic significance in patients with pneumonia. The study followed 976 patients hospitalised for community-acquired pneumonia and looked at all-cause mortality at 90 days and 3 years. Mortality was significantly higher in the group who had a fall in platelets (by more than 50×109/L) during their admission compared with those whose platelets rose (by more than 50×109/L) or had no change (p<0.001). Mortality was also significantly higher in those with thrombocytopenia on discharge. A rising platelet count during admission was found to be a powerful predictor of better survival. Platelet count changes could be used as a prognostic marker for pneumonia.

Azithromycin in asthma

Azithromycin as a long-term antibiotic is being increasing used in a range of respiratory conditions. The AZALEA trial (JAMA Internal Medicine doi: 10.1001/jamainternmed.2016.5664) studied whether a short course of azithromycin had any benefit in the treatment …

View Full Text